More
    Guided Solutions - Connecting Talent With Innovation/div>

    Medtronic enrolls first patients in Hugo surgical robot clinical trial

    Medtronic (NYSE:MDT) announced that it enrolled the first patient in its Expand URO U.S. clinical trial for the Hugo surgical robot. Dr. Michael R. Abern...

    Valo Health – FDA Collaborative Study in Human Cardiac Tissues Demonstrates Potential to Predict Clinical Efficacy of Cardiac Contractility Modulation Devices to Treat Heart...

    Findings Part of Five-Year Research Collaboration Between Valo and FDA Developed on Valo's Biowire Platform Valo Health, Inc ("Valo") shared the initial results of a collaborative...

    Moon Surgical Announces Successful Completion of First-in-Human Clinical Study with Maestro™ Surgical Robot

    Moon Surgical announces the successful completion of 30 First-in-Human laparoscopy procedures using its Maestro System at CHU Saint-Pierre, a public university hospital in Brussels, Belgium. Maestro...

    Elekta Announces Radiation Therapy Milestone

    Elekta has announced the first ever patient treated for pancreatic cancer with new advanced radiotherapy motion management using Elekta Unity MR-Linac. Last week, the first...

    Medtronic concludes final treatment in Sphere-9 ablation catheter trial

    Medtronic concludes final treatment in Sphere-9 ablation catheter trial Medtronic has completed participant enrolment and final treatment in the SPHERE Per-AF Trial of its Sphere-9 pulsed field (PF)...

    New Publication Supports Clinical Effectiveness of Centinel Spine’s Stand-Alone STALIF® M Integrated Interbody™ Portfolio

    Study conducted by the Texas Back Institute (TBI), Plano, TX and published in the International Journal of Spine Surgery The retrospective study supports utilizing STALIF M portfolio implants as...

    Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2™ Aortic Valve System

    Boston Scientific Corporation (NYSE:BSX) has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the...

    New results detail J&J Embotrap design’s first-pass performance in stroke patients

    Johnson & Johnson (NYSE:JNJ) has released results for its Embotrap stent retrievers showing the next-generation design’s success in removing blood clots from ischemic stroke patients. Johnson...

    Mainstay Medical Announces Publication of Post-Market Clinical Trial Data from Ongoing ReActiv8®-C Study in Chronic Low Back Pain Patients

    New real-world evidence further supports the efficacy and use of ReActiv8® Restorative Neurostimulation™ for the treatment of intractable Chronic Low Back Pain Mainstay Medical Holdings...

    Latest articles